GRS Meetings 2008

Meeting number 42
Date 10/14/2008
Topic HIV accessory genes: in quest of essentiality
Organizer Gianfranco Pancino
Speakers

Serge Bénichou
Institut Cochin, Inserm U567, CNRS UMR8104, Paris
Vpr: a player in the early steps of the viral replication cycle

Andrea Cimarelli
Ecole Normale Supérieure de Lyon, INSERM U758, LaboRetro, Human Virology
Vpx role in the infection of myeloid cells
Florence Margottin-Goguet
Equipe AVENIR C3PV  "Contrôle du Cycle Cellulaire et Proteines Virales", Institut Cochin, Paris
How does the Vpu protein promote viral particle release?

 

Meeting number 41
Date 09/16/2008
Topic Tregs in HIV infection
Organizer Laurence Weiss
Speakers

Lisa Chakrabarti
Unité d'Immunogénétique Cellulaire, Institut Pasteur, Paris
Homeostatic regulation of Tregs: role of IL-2 and IL-7

Claire Chougnet
Cincinnati Children's Hospital Medical Center, USA
Regulatory T cells in HIV infection: a complex balancing act
Laurence Weiss
Unité de Régulation des Infections Rétrovirales, Institut Pasteur, Paris
Regulatory T cells and immune activation in HIV infected patients under efficient antiretroviral therapy and after 12 month treatment interruption: the ANRS 116 SALTO trial

 

Meeting number 40
Date 05/29/2008
Topic HIV resistance to antiretroviral therapy
Organizer Jacques Thèze
Speakers

Mark Wainberg
McGill University, AIDS Center, Montreal, Canada
Differences between HIV subtypes regarding resistance to therapy: consequences on public health and prevention programs

 

Meeting number 39
Date 05/29/2008
Topic Immunotherapy of HIV infection
Organizer Jacques Thèze
Speakers

Cliff Lane
Director of Clinical Research, NIAID, NIH, Bethesda, USA
IL-2, IL-7, and IL-15: the role of gamma-c cytokines as immune based therapies in HIV infection

Irini Sereti
NIAID, NIH, Bethesda, USA
IL-2 and IL-7 in HIV infection: from bench to bedside and back

 

Meeting number 38
Date 04/10/2008
Topic GMO plants and vaccines against HIV and HBV
Organizer Gianfranco Pancino
Speakers

David Tepfer
Physicochimie et Ecotoxicologie des Sols d'Agrosystèmes Contaminés (PESSAC), INRA, Versailles
Plants and Biotechnology: How and Why

Tomascz Pniewski
Laboratory of Structural Genomics, Plant Genetics Institute, Polish Science Academy of Poznan, Poland
Plant-derived new generation vaccine against Hepatitis B
Monica Sala
Unité de Rétrovirologie Moléculaire, Institut Pasteur, Paris
An HIV-1 vaccine by oral administration of transgenic plants: a novel approach to vectorization

 

Meeting number 37
Date 03/18/2008
Topic HIV integrase inhibitors
Organizer Lisa Chakrabarti
Speakers

Jean-François Mouscadet
CNRS UMR 8113, Ecole Normale Supérieure de Cachan, Cachan
Introduction: the role of Integrase in the HIV life cycle

Catherine Dargemont
CNRS UMR 7592, Institut Jacques Monod, Paris
HIV integrase cellular partners
Jean-François Mouscadet
CNRS UMR 8113, Ecole Normale Supérieure de Cachan, Cachan
Mechanisms of action of integrase inhibitors
Jade Ghosn
Service de Médecine Interne et Maladies Infectieuses, Hôpital du Kremlin-Bicêtre
Clinical use of integrase inhibitors

 

Meeting number 36
Date 01/22/2008
Topic HIV and the Immune Reconstitution Inflammatory Syndrome: "In the eye of IRIS "
Organizer Claudine Duvivier
Speakers

Guillaume Breton
Service de Médecine Interne, Hôpital Pitié-Salpêtrière, Paris
IRIS: from concept to practice

Homa Adle
Service d'Anatomopathologie de l'Hôpital Bichat-Claude Bernard, Paris
Different IRIS forms in anatomopathology
Anne Bourgarit
Service de Médecine Interne, Hôpital Saint-Louis, INSERM U543, Paris
Physiopathology of IRIS
Bob Colebunders
Institute of Tropical Medicine, Anvers University, Belgium
IRIS in countries with limited resources